Semin Thromb Hemost 2017; 43(04): 433-438
DOI: 10.1055/s-0037-1599155
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Point-of-Care Testing in Burn Patients

Marion Wiegele
1   Division of General Anaesthesia and Intensive Care Medicine, Department of Anaesthesia, Critical Care and Pain Medicine, Medical University of Vienna, Vienna, Austria
,
Sibylle Kozek-Langenecker
2   Department of Anaesthesia and Intensive Care, Evangelical Hospital Vienna, Vienna, Austria
,
Eva Schaden
1   Division of General Anaesthesia and Intensive Care Medicine, Department of Anaesthesia, Critical Care and Pain Medicine, Medical University of Vienna, Vienna, Austria
› Author Affiliations
Further Information

Publication History

Publication Date:
30 March 2017 (online)

Abstract

Severe burn injury has an impact on the coagulation system, but a unique definition regarding these changes is still missing. The results of conventional coagulation assays (CCAs) measured in daily clinical practice are often interpreted as coagulopathic, which implies a bleeding tendency. However, viscoelastic coagulation assays (VCA) like Rotational Thromboelastometry (ROTEM) and Thromboelastography (TEG) depict a hypercoagulable state. Therefore, hemostatic interventions should not be indicated according to deranged CCA results, but only in case of clinically relevant bleeding plus indicative VCA results. Massive blood loss mainly results from surgical excision of burn wounds. VCAs seem to be capable of guiding target-oriented coagulation management in this context. Owing to the increased thromboembolic risk, it appears rational to individualize pharmacologic venous thromboembolism prophylaxis by using sensitive laboratory tests and drug monitoring. Studies evaluating the use of new VCA test modifications are highly warranted and may substantially improve outcome in this difficult-to-treat patient population.

 
  • References

  • 1 Hans GA, Besser MW. The place of viscoelastic testing in clinical practice. Br J Haematol 2016; 173 (01) 37-48
  • 2 Kitchen DP, Jennings I, Kitchen S, Woods TA, Walker ID. Bridging the gap between point-of-care testing and laboratory testing in hemostasis. Semin Thromb Hemost 2015; 41 (03) 272-278
  • 3 Faraoni D, Savan V, Levy JH, Theusinger OM. Goal-directed coagulation management in the perioperative period of cardiac surgery. J Cardiothorac Vasc Anesth 2013; 27 (06) 1347-1354
  • 4 Siller-Matula JM, Francesconi M, Dechant C. , et al. Personalized antiplatelet treatment after percutaneous coronary intervention: the MADONNA study. Int J Cardiol 2013; 167 (05) 2018-2023
  • 5 Solomon C, Traintinger S, Ziegler B. , et al. Platelet function following trauma. A multiple electrode aggregometry study. Thromb Haemost 2011; 106 (02) 322-330
  • 6 Hartert H. Blutgerinnungsstudien mit der Thrombelastographie; einem neuen Untersuchungs verfahren. [Blood coagulation studies with thrombelastography: a new evaluation technique] Klin Wochenschr 1948; 26 (37-38): 577-583
  • 7 Nogami K. The utility of thromboelastography in inherited and acquired bleeding disorders. Br J Haematol 2016; 174 (04) 503-514
  • 8 Mallett SV. Clinical utility of viscoelastic tests of coagulation (TEG/ROTEM) in patients with liver disease and during liver transplantation. Semin Thromb Hemost 2015; 41 (05) 527-537
  • 9 Park MS, Martini WZ, Dubick MA. , et al. Thromboelastography as a better indicator of hypercoagulable state after injury than prothrombin time or activated partial thromboplastin time. J Trauma 2009; 67 (02) 266-275 , discussion 275–276
  • 10 Roullet S, Pillot J, Freyburger G. , et al. Rotation thromboelastometry detects thrombocytopenia and hypofibrinogenaemia during orthotropic liver transplantation. Br J Anaesth 2010; 104 (04) 422-428
  • 11 Theusinger OM, Stein P, Levy JH. Point of care and factor concentrate-based coagulation algorithms. Transfus Med Hemother 2015; 42 (02) 115-121
  • 12 Dai Y, Lee A, Critchley LA, White PF. Does thromboelastography predict postoperative thromboembolic events? A systematic review of the literature. Anesth Analg 2009; 108 (03) 734-742
  • 13 Kaufmann CR, Dwyer KM, Crews JD, Dols SJ, Trask AL. Usefulness of thrombelastography in assessment of trauma patient coagulation. J Trauma 1997; 42 (04) 716-720 , discussion 720–722
  • 14 Schaden E, Hoerburger D, Hacker S, Kraincuk P, Baron DM, Kozek-Langenecker S. Fibrinogen function after severe burn injury. Burns 2012; 38 (01) 77-82
  • 15 Schaden E, Kimberger O, Kraincuk P, Baron DM, Metnitz PG, Kozek-Langenecker S. Perioperative treatment algorithm for bleeding burn patients reduces allogeneic blood product requirements. Br J Anaesth 2012; 109 (03) 376-381
  • 16 Van Haren RM, Thorson CM, Valle EJ. , et al. Hypercoagulability after burn injury. J Trauma Acute Care Surg 2013; 75 (01) 37-43 , discussion 43
  • 17 Kozek-Langenecker SA, Afshari A, Albaladejo P. , et al. Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology. Eur J Anaesthesiol 2013; 30 (06) 270-382
  • 18 Goobie SM, Haas T. Perioperative bleeding management in pediatric patients. Curr Opin Anaesthesiol 2016; 29 (03) 352-358
  • 19 Schlembach D, Mörtl MG, Girard T. , et al. Management of postpartum hemorrhage (PPH): algorithm of the interdisciplinary D-A-CH consensus group PPH (Germany - Austria - Switzerland) [in German]. Anaesthesist 2014; 63 (03) 234-242
  • 20 Levi M, Hunt BJ. A critical appraisal of point-of-care coagulation testing in critically ill patients. J Thromb Haemost 2015; 13 (11) 1960-1967
  • 21 Da Luz LT, Nascimento B, Shankarakutty AK, Rizoli S, Adhikari NK. Effect of thromboelastography (TEG®) and rotational thromboelastometry (ROTEM®) on diagnosis of coagulopathy, transfusion guidance and mortality in trauma: descriptive systematic review. Crit Care 2014; 18 (05) 518
  • 22 Deppe AC, Weber C, Zimmermann J. , et al. Point-of-care thromboelastography/thromboelastometry-based coagulation management in cardiac surgery: a meta-analysis of 8332 patients. J Surg Res 2016; 203 (02) 424-433
  • 23 Debernardi Venon W, Ponzo P, Sacco M. , et al. Usefulness of thromboelastometry in predicting the risk of bleeding in cirrhotics who undergo invasive procedures. Eur J Gastroenterol Hepatol 2015; 27 (11) 1313-1319
  • 24 Schaden E, Saner FH, Goerlinger K. Coagulation pattern in critical liver dysfunction. Curr Opin Crit Care 2013; 19 (02) 142-148
  • 25 Tripodi A, Anstee QM, Sogaard KK, Primignani M, Valla DC. Hypercoagulability in cirrhosis: causes and consequences. J Thromb Haemost 2011; 9 (09) 1713-1723
  • 26 Müller MC, Meijers JC, Vroom MB, Juffermans NP. Utility of thromboelastography and/or thromboelastometry in adults with sepsis: a systematic review. Crit Care 2014; 18 (01) R30
  • 27 Vahtera A, Vaara S, Pettilä V, Kuitunen A. Plasma anti-FXa level as a surrogate marker of the adequacy of thromboprophylaxis in critically ill patients: A systematic review. Thromb Res 2016; 139: 10-16
  • 28 Boonyawat K, Crowther MA. Venous thromboembolism prophylaxis in critically ill patients. Semin Thromb Hemost 2015; 41 (01) 68-74
  • 29 Schaden E, Schober A, Hacker S, Spiss C, Chiari A, Kozek-Langenecker S. Determination of enoxaparin with rotational thrombelastometry using the prothrombinase-induced clotting time reagent. Blood Coagul Fibrinolysis 2010; 21 (03) 256-261
  • 30 Adelmann D, Wiegele M, Wohlgemuth RK. , et al. Measuring the activity of apixaban and rivaroxaban with rotational thrombelastometry. Thromb Res 2014; 134 (04) 918-923
  • 31 Barco S, Nijkeuter M, Middeldorp S. Pregnancy and venous thromboembolism. Semin Thromb Hemost 2013; 39 (05) 549-558
  • 32 Huissoud C, Carrabin N, Benchaib M. , et al. Coagulation assessment by rotation thrombelastometry in normal pregnancy. Thromb Haemost 2009; 101 (04) 755-761
  • 33 Sultan AA, West J, Tata LJ, Fleming KM, Nelson-Piercy C, Grainge MJ. Risk of first venous thromboembolism in and around pregnancy: a population-based cohort study. Br J Haematol 2012; 156 (03) 366-373
  • 34 Welsby I, Ortel TL. Is it time for individualized thromboprophylaxis regimens in the ICU?. Crit Care Med 2015; 43 (02) 500-501
  • 35 Schöchl H, Nienaber U, Hofer G. , et al. Goal-directed coagulation management of major trauma patients using thromboelastometry (ROTEM)-guided administration of fibrinogen concentrate and prothrombin complex concentrate. Crit Care 2010; 14 (02) R55
  • 36 Hiippala ST, Myllylä GJ, Vahtera EM. Hemostatic factors and replacement of major blood loss with plasma-poor red cell concentrates. Anesth Analg 1995; 81 (02) 360-365
  • 37 Glas GJ, Levi M, Schultz MJ. Coagulopathy and its management in patients with severe burns. J Thromb Haemost 2016; 14 (05) 865-874
  • 38 Lippi G, Ippolito L, Cervellin G. Disseminated intravascular coagulation in burn injury. Semin Thromb Hemost 2010; 36 (04) 429-436
  • 39 Lavrentieva A, Kontakiotis T, Bitzani M. , et al. Early coagulation disorders after severe burn injury: impact on mortality. Intensive Care Med 2008; 34 (04) 700-706
  • 40 Meizoso JP, Ray JJ, Allen CJ. , et al. Hypercoagulability and venous thromboembolism in burn patients. Semin Thromb Hemost 2015; 41 (01) 43-48
  • 41 Schöchl H, Voelckel W, Maegele M, Kirchmair L, Schlimp CJ. Endogenous thrombin potential following hemostatic therapy with 4-factor prothrombin complex concentrate: a 7-day observational study of trauma patients. Crit Care 2014; 18 (04) R147
  • 42 Shakur H, Roberts I, Bautista R. , et al; CRASH-2 trial collaborators. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet 2010; 376 (9734): 23-32